GEFITINIB Pharmacologic Class Indexing
- Class set ID
- 273cb754-93c6-45c2-95f3-dc1b21c17f6b
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use GEFITINIB TABLETS safely and effectively. See full prescribing information for GEFITINIB TABLETS. GEFITINIB tablets, for oral use Initial U.S. Approval: 2015 | Natco Pharma USA LLC | 20260310 | 4 |
| These highlights do not include all the information needed to use GEFITINIB TABLETS safely and effectively. See full prescribing information for GEFITINIB TABLETS. GEFITINIB tablets, for oral use Initial U.S. Approval: 2015 | Ingenus Pharmaceuticals, LLC | Qilu Pharmaceutical (Hainan) Co., Ltd. | 20231228 | 3 |
| These highlights do not include all the information needed to use IRESSA ® safely and effectively. See full prescribing information for IRESSA. IRESSA (gefitinib) tablets for oral use Initial U.S. Approval: 2015 | AstraZeneca Pharmaceuticals LP | 20230228 | 19 |
| These highlights do not include all the information needed to use GEFITINIB TABLETS safely and effectively. See full prescribing information for GEFITINIB TABLETS GEFITINIB tablets, for oral use Initial U.S. Approval: 2015 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. | 20230222 | 7 |
| These highlights do not include all the information needed to use GEFITINIB TABLETS safely and effectively. See full prescribing information for GEFITINIB TABLETS . GEFITINIB tablets, for oral use Initial U.S. Approval: 2015 | Teva Pharmaceuticals, Inc. | 20220228 | 5 |